Effects of sorafenib combined with arsenic trioxide on the expression of surface drug resistance protein P-glycoprotein in patients with primary hepatocellular carcinoma and its clinical efficacy

LIN Rongsheng; WU Chuhai; WANG Tao

doi:10.3969/j.issn.1002-7386.2020.05.016

Home>Articles>Effects of sorafenib combined with arsenic trioxide on the expression of surface drug resistance protein P-glycoprotein in patients with primary hepatocellular carcinoma and its clinical efficacy

DOI: 10.3969/j.issn.1002-7386.2020.05.016

Effects of sorafenib combined with arsenic trioxide on the expression of surface drug resistance protein P-glycoprotein in patients with primary hepatocellular carcinoma and its clinical efficacy

LIN Rongsheng

WU Chuhai

WANG Tao

Machine-generated Keywords：

Publication Date：2020-03-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 710-713 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2020,42(5)